Immutep Ltd Sees Increased Stake from Regal Funds - TipRanks
| PRRUF Stock | USD 0.20 0.00 0.00% |
Roughly 60% of Immutep's investor base is looking to short. The analysis of overall sentiment of trading Immutep Limited pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Immutep's historical and current headlines, can help investors time the market. In addition, many technical investors use Immutep Limited stock news signals to limit their universe of possible portfolio assets.
Immutep pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immutep daily returns and investor perception about the current price of Immutep Limited as well as its diversification or hedging effects on your existing portfolios.
Immutep |
Immutep Ltd Sees Increased Stake from Regal Funds TipRanks
Read at news.google.com
 |
Immutep Fundamental Analysis
We analyze Immutep's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Immutep is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Immutep Limited Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immutep pink sheet to make a market-neutral strategy. Peer analysis of Immutep could also be used in its relative valuation, which is a method of valuing Immutep by comparing valuation metrics with similar companies.
Peers
Immutep Related Equities
| OLMA | Olema Pharmaceuticals | 7.20 | ||||
| ALXO | Alx Oncology | 6.75 | ||||
| DSGN | Design Therapeutics | 6.75 | ||||
| VRDN | Viridian Therapeutics | 6.27 | ||||
| ELEV | Elevation Oncology | 5.97 | ||||
| APLT | Applied Therapeutics | 4.84 | ||||
| ADCT | ADC Therapeutics | 4.57 | ||||
| ALVR | Allovir | 3.11 | ||||
| CRNX | Crinetics Pharmaceuticals | 2.38 | ||||
| CDTX | Cidara Therapeutics | 2.12 | ||||
| SLN | Silence Therapeutics | 1.79 | ||||
| CGEM | Cullinan Oncology | 1.18 | ||||
| GPCR | Structure Therapeutics | 0.30 | ||||
| IMMX | Immix Biopharma | 0.97 | ||||
| CTMX | CytomX Therapeutics | 1.18 | ||||
| ZURA | Zura Bio | 1.67 | ||||
| CYTK | Cytokinetics | 2.66 | ||||
| SANA | Sana Biotechnology | 2.77 | ||||
| ENVB | Enveric Biosciences | 2.78 | ||||
| AADI | Aadi Bioscience | 4.79 | ||||
| ZNTL | Zentalis Pharmaceuticals | 6.28 |
Complementary Tools for Immutep Pink Sheet analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |